Efficacy and Safety of Acupuncture at Xinshu (BL15), Jueyinshu (BL14) and Yishu (EX-B3) for Cardiac Autonomic Neuropathy in Patients With Type 2 Diabetes

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07907536

Title field or adapter rule

{'original_value': 'Efficacy and Safety of Acupuncture at Xinshu (BL15), Jueyinshu (BL14) and Yishu (EX-B3) for Cardiac Autonomic Neuropathy in Patients With Type 2 Diabetes', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:34.317800+00:00

Published At

2026-10-30T00:00:00+00:00

Record Updated At

2026-10-30

Source Retrieved At

2026-10-31T22:18:45.365006+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Diabetic Cardiovascular Autonomic Neuropathy", "Type 2 Diabetes Mellitus", "Diabetic Neuropathies"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-30", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT07907536"

protocolSection.identificationModule.officialTitle

"Efficacy and Safety of Acupuncture at Xinshu (BL15), Jueyinshu (BL14) and Yishu (EX-B3) for Cardiac Autonomic Neuropathy in Patients With Type 2 Diabetes"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["NA"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Diabetic Cardiovascular Autonomic Neuropathy (protocolSection.conditionsModule.conditions)
• Type 2 Diabetes Mellitus (protocolSection.conditionsModule.conditions)
• Diabetic Neuropathies (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Acupuncture Plus Mecobalamin'], 'description': 'Manual acupuncture at three main back-shu points: Xinshu (BL15), Jueyinshu (BL14) and Yishu (EX-B3). The even reinforcing-reducing method is used until deqi (needle sensation) is obtained, and needles are retained for 15 minutes. Treatment is given 3 times a week for 6 weeks, in addition to standard glucose-lowering treatment and oral mecobalamin.', 'name': 'Acupuncture', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Acupuncture Plus Mecobalamin', 'Mecobalamin Alone'], 'description': 'Oral mecobalamin tablets, 0.5 mg (1 tablet) three times daily for 6 weeks, given together with standard glucose-lowering treatment (glycemic target HbA1c \\< 7.0%). Given to both groups.', 'name': 'Mecobalamin', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Mecobalamin (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.